International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

Pancreatology

Volumn 12, Issue 3, 2012, Pages 183-197

  Tanaka, Masao ^a   Fernández Del Castillo, Carlos ^b   Adsay, Volkan ^c   Chari, Suresh ^d   Falconi, Massimo ^e   Jang, Jin Young ^f   Kimura, Wataru ^g   Levy, Philippe ^h   Pitman, Martha Bishop ^b   Schmidt, C Max ⁱ   Shimizu, Michio ^j   Wolfgang, Christopher L ^k   Yamaguchi, Koji ^l   Yamao, Kenji ^m  

^a KYUSHU UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

^e UOC Oncoematologia Pediatrica Policlinico GB Rossi   (Italy)

^f Seoul National University College of Medicine   (South Korea)

^g YAMAGATA UNIVERSITY   (Japan)

^h BEAUJON HOSPITAL   (France)

ⁱ INDIANA UNIVERSITY   (United States)

^j SAITAMA MEDICAL UNIVERSITY   (Japan)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^m AICHI CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

International guidelines; Intraductal papillary mucinous neoplasm; Mucinous cystic neoplasm

Indexed keywords

ALCOHOL; CARCINOEMBRYONIC ANTIGEN; GADOLINIUM;

ABLATION THERAPY; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYST FLUID; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FAMILY HISTORY; FOLLOW UP; FROZEN SECTION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MUCINOUS CYSTIC NEOPLASM; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CYST; PANCREAS DUCT; PANCREAS JUICE; PANCREAS PSEUDOCYST; PANCREAS RESECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

EID: 84862168016     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.04.004     Document Type: Conference Paper

References (200)

1. Tanaka M, Chari S, Adsay V, Fernández-del Castillo C, Falconi M, Shimizu M, et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
2. Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40: 856-62. (Pubitemid 44506933)
3. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-51. discussion 651-654. (Pubitemid 47480616)
4. Nagai K, Doi R, Kida A, Kami K, Kawaguchi Y, Ito T, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 2008;32:271-8. discussion 279-280.
5. Hwang DW, Jang JY, Lee SE, Lim CS, Lee KU, Kim SW. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg 2012;397:93-102.
6. Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, et al. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol 2010;44:e224-229.
7. Bournet B, Kirzin S, Carrere N, Portier G, Otal P, Selves J, et al. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. J Gastroenterol Hepatol 2009;24:1211-7.
8. Waters JA, Schmidt CM, Pinchot JW, White PB, Cummings OW, Pitt HA, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12:101-9.
9. Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma.AmJ Roentgenol 2006;186:687-95.
10. Crippa S, Fernández-del Castillo C, Salvia R, Finkelstein D, Bassi C, Domingues I, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010;8:213-9.
11. Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003;90:1244-9. (Pubitemid 37330429)
12. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788-97. discussion 797-799.
13. Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2004;239:678-87.
14. Suzuki Y, Atomi Y, Sugiyama M, Isaji S, Inui K, Kimura W, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004;28: 241-6. (Pubitemid 38437316)
15. Lee SY, Lee KT, Lee JK, Jeon YH, Choi D, Lim JH, et al. Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 2005;20:1379-84. (Pubitemid 43960835)
16. Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 2008;143:639-46. discussion 646. (Pubitemid 352040228)
17. Kim SC, Park KT, Lee YJ, Lee SS, Seo DW, Lee SK, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 2008;15:183-8. (Pubitemid 351516977)
18. Ohno E, Hirooka Y, Itoh A, Ishigami M, Katano Y, Ohmiya N, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasonography findings of mural nodules. Ann Surg 2009;249:628-34.
19. Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, et al. Preoperative evaluation of invasive and noninvasive intraductal papillarymucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 2009;38:8-16.
20. Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-9. (Pubitemid 47031144)
21. Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 2008;15: 199-205.
22. Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010;39:232-6.
23. Kanno A, Satoh K, Hirota M, Hamada S, Umino J, Itoh H, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 2010;45:952-9.
24. Baiocchi GL, Portolani N, Missale G, Baronchelli C, Gheza F, Cantù M, et al. Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinicopathological correlations and surgical indications. World J Surg Oncol 2010;8:25 [online].
25. Fernández-del Castillo C. Intraductal papillary mucinous neoplasms of the pancreas: a plea for prospective differentiation between main-duct and sidebranch tumors. Ann Surg Oncol 2005;12:98-9. (Pubitemid 40486614)
26. Adsay NV, Fukushima N, Furukawa T, Hruban RH, Klimstra DS, Kloppel G, et al. Intraductal neoplasm of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumors of digestive system. Lyon: WHO Press; 2010. p. 304-13.
27. Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: Silverberg SG, editor. AFIP Atlas of tumor pathology series 4, vol. 6. Washington: ARP Press; 2007. p. 75-110.
28. Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: Depiction on single-shot fast spin-echo MR images. Radiology 2002;223: 547-53. (Pubitemid 34454341)
29. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, et al. Cystic pancreatic neoplasms: observe or operate. Ann Surg 2004;239: 651-9. (Pubitemid 38525636)
30. Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol 2008;191:802-7.
31. Das A, Wells CD, Nguyen CC. Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? Am J Gastroenterol 2008;103: 1657-62.
32. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138. 427-423; discussion 433-434.
33. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: White paper of the ACR incidental findings committee. J Am Col Radiol 2010;7:754-73.
34. Bassi C, Crippa S, Salvia R. Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife? Gut 2008;57:287-9. (Pubitemid 351288090)
35. Brounts LR, Lehmann RK, Causey MW, Sebesta JA, Brown TA. Natural course and outcome of cystic lesions in the pancreas. Am J Surg 2009;197:619-23.
36. Javle M, Shah P, Yu J, Bhagat V, Litwin A, Iyer R, et al. Cystic pancreatic tumors (CPT): predictors of malignant behavior. J Surg Oncol 2007;95:221-8.
37. Lee SH, Shin CM, Park JK, Woo SM, Yoo JW, Ryu JK, et al. Outcomes of cystic lesions in the pancreas after extended follow-up. Dig Dis Sci 2007;52: 2653-9. (Pubitemid 47373885)
38. Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 2007;56:1086-90.
39. Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 2011;8:56-60.
40. Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2004;2:1026-31. (Pubitemid 39539753)
41. Fukushima N, Mukai K. Pancreatic neoplasms with abundant mucus production: emphasis on intraductal papillary-mucinous tumors and mucinous cystic tumors. Adv Anat Pathol 1999;6:65-77.
42. Itai Y, Minami M. Intraductal papillary-mucinous tumor and mucinous cystic neoplasm: CT and MR findings. Int J Gastrointest Cancer 2001;30:47-63. (Pubitemid 36330129)
43. Kimura W. IHPBA in Tokyo surgical treatment of IPMT vs MCT: a Japanese experience. J Hepatobiliary Pancreat Surg 2002;2003(10):156-62. (Pubitemid 37160941)
44. Solcia E, Capella C, Klöppel G. Tumors of the pancreas. In: Rosai J, editor. Atlas of tumor pathology. 3rd ed., vol. 20. Washington, D.C: Armed Forces Institute of Pathology; 1997.
45. Khalid A, McGrath KM, Zahid M, Wilson M, Brody D, Swalsky P, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005;3:967-73. (Pubitemid 41415743)
46. Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095-102.
47. Shen J, Brugge WR, Dimaio CJ, Pitman MB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer 2009;117:217-27.
48. Sahani DV, Lin DJ, Venkatesan AM, Sainani N, Mino-Kenudson M, Brugge WR, et al. Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol 2009;7:259-69.
49. Sahani DV, Kadavigere R, Saokar A, Fernández CC, Brugge WR, Hahn PF. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005;25:1471-84. (Pubitemid 41695317)
50. Pitman MB, Deshpande V. Endoscopic ultrasound-guided fine needle aspiration cytology of the pancreas: a morphological and multimodal approach to the diagnosis of solid and cystic mass lesions. Cytopathology 2007;18: 331-47. (Pubitemid 350145655)
51. Pitman MB, Genevay M, Yaeger K, Chebib I, Turner BG, Mino-Kenudson M, et al. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than "positive" cytology. Cancer Cytopathol 2010;118:434-40.
52. Lee CJ, Scheiman J, Anderson MA, Hines OJ, Reber HA, Farrell J, et al. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 2008;12:234-42
53. Park WG, Mascarenhas R, Palaez-Luna M, Smyrk TC, O'Kane D, Clain JE, et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas 2011;40:42-5.
54. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330-6. (Pubitemid 38552797)
55. Cizginer S, Turner B, Bilge AR, Karaca C, Pitman MB, Brugge WR. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40:1024-8.
56. Genevay M, Mino-Kenudson M, Yaeger K, Ioannis T, Konstantinidis IT, Ferrone CR, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011;254:977-83.
57. Sainani NI, Saokar A, Deshpande V, Fernandez-del Castillo C, Hahn P, Sahani DV. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. Am J Roentgenol 2009;193:722-31.
58. Nakagawa A, Yamaguchi T, Ohtsuka M, Ishihara T, Sudo K, Nakamura K, et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single-detector computed tomography and endoscopic ultrasonography. Pancreas 2009;38:131-6.
59. Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011, 3, 92-66.
60. Sahani DV, Kadavigere R, Blake M, Fernández-del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multidetector row CT with 2D curved reformationsecorrelation with MRCP. Radiology 2006;238:560-9. (Pubitemid 43134368)
61. Pitman MB. Cytology of the pancreas. In: Gray W, Kocjan G, editors. Diagnostic cytopathology. London: Churchill Livingstone; 2010.
62. Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL. Fernándezdel Castillo C. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010;10:144-50.
63. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005;62:383-9. (Pubitemid 41187940)
64. Frossard JL, Amouyal P, Amouyal G, Palazzo L, Amaris J, Soldan M, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.Am J Gastroenterol 2003;98:1516-24.
65. Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshpande V. Serous cystadenoma of the pancreas: limitations and pitfalls of endoscopic ultrasoundguided fine-needle aspiration biopsy. Cancer 2008;114:102-10. (Pubitemid 351640789)
66. Recine M, Kaw M, Evans DB, Krishnamurthy S. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 2004;102:92-9. (Pubitemid 38489966)
67. Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006;108:163-73.
68. Layfield LJ, Cramer H. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis. Diagn Cytopathol 2005; 32:16-20. (Pubitemid 40024068)
69. Emerson RE, Randolph ML, Cramer HM. Endoscopic ultrasound-guided fineneedle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia. Diagn Cytopathol 2006;34:457-62.
70. Maire F, Couvelard A, Hammel P, Ponsot P, Palazzo L, Aubert A, et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc 2003;58: 701-6. (Pubitemid 37370483)
71. Maire F, Voitot H, Aubert A, Palazzo L, O'Toole D, Couvelard A, et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol 2008;103:2871-7.
72. Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC. Cytological and cyst fluid analysis of small (≤3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology 2008;8:277-84. (Pubitemid 351832481)
73. Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, et al. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 2003;138:610-7. discussion 617-618.
74. Yamao K, Yanagisawa A, Takahashi K, Kimura W, Doi R, Fukushima N, et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan Pancreas Society. Pancreas 2011;40:67-71.
75. Hirooka Y, Goto H, Itoh A, Hashimoto S, Niwa K, Ishikawa H, et al. Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination. J Gastroenterol Hepatol 2003;18:1323-7.
76. Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M, et al. Pancreatic juice cytology in IPMN of the pancreas. Pancreatology 2005; 5:416-21. discussion 421. (Pubitemid 41160280)
77. Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, et al. The carcinoembryonic antigen level in the pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg in press.
78. Procacci C, Graziani R, Bicego E, Bergamo-Andreis IA, Guarise A, Valdo M, et al. Serous cystadenoma of the pancreas: report of 30 cases with emphasis on the imaging findings. J Comput Assist Tomogr 1997;21:373-82. (Pubitemid 27212413)
79. Choi JY, Kim MJ, Lee JY, Lim JS, Chung JJ, Kim KW, et al. Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathological correlation. Am J Roentgenol 2009;193:136-42.
80. Goh BKP, Tan YM, Yap WM, Cheow PC, Chow PK, Chung YF, et al. Pancreatic serous oligocystic adenomas: clinicopathological features and a comparison with serous microcystic and mucinous cystic neoplasms. World J Surg 2006; 30:1553-9. (Pubitemid 44421261)
81. Kim SY, Lee JM, Kim SH, Shin KS, Kim YJ, An SK, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. Am J Roentgenol 2006;187:1192-8. (Pubitemid 44630821)
82. Cohen-Scali F, Vilgrain V, Brancatelli G, Hammel P, Vullierme MP, Sauvanet A, et al. Discrimination of unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma with CT: initial observations. Radiology 2003;228:727-33. (Pubitemid 37025483)
83. Couvelard A, Sauvanet A, Kianmanesh R, Hammel P, Colnot N, Levy P, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg 2005;242:778-80. discussion, 774-778.
84. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12:124-32. (Pubitemid 40486620)
85. White R, D'Angelica M, Katabi N, Tang L, Klimstra D, Fong Y, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 2007;204:987-93. (Pubitemid 46661196)
86. Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500-7. (Pubitemid 35231650)
87. Farnell MB. Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg 2008;12:414-6.
88. Crippa S, Tamburrino D, Partelli S, Salvia R, Germenia S, Bassi C, et al. Total pancreatectomy: indications, different timing, and perioperative and longterm outcomes. Surgery 2011;149:79-86.
89. Stauffer JA, Nguyen JH, Heckman MG, Grewal MS, Dougherty M, Gill KR, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford) 2009;11:483-92.
90. Cheon YK, Cho YD, Jeon SR, Moon JH, Jeong SW, Hur KY, et al. Pancreatic resection guided by preoperative intraductal ultrasonography for intraductal papillary mucinous neoplasm. Am J Gastroenterol 2010;105:1963-9.
91. Eguchi H, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T, Nakaizumi A, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer 2006;107:2567-75. (Pubitemid 44845609)
92. Kang MJ, Jang JY, Kim SJ, Lee KB, Ryu JK, Kim YT, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 2011;9:87-93.
93. Lévy P, Jouannaud V, O'Toole D, Couvelard A, Vullierme MP, Palazzo L, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 2006;4:460-8.
94. Nagai K, Doi R, Ito T, Koizumi M, Masui T, Kawaguchi Y, et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009;16:353-8.
95. Sai JK, Suyama M, Kubokawa Y, Watanabe S, Maehara T. Pancreatic- ductlavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the international consensus guidelines be revised? Gastrointest Endosc 2009;69: 434-40.
96. Rautou PE, Levy P, Vullierme MP, O'Toole D, Couvelard A, Cazals-Hatem D, et al. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study. Clin Gastroenterol Hepatol 2008;6:807-14.
97. Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markovbased clinical nomograms. Gastroenterology 2010;138:531-40.
98. Crippa S, Salvia R, Warshaw AL, Dominguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008;247:571-9. (Pubitemid 351440607)
99. Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999;23: 410-22. (Pubitemid 29160001)
100. Sarr MG, Carpenter HA, Prabhakar LP, Orchard TF, Hughes S, van Heerden JA, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000;231:205-12. (Pubitemid 30078803)
101. Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999; 229:693-8.
102. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt MC, Merchant NB, et al. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 2008;248:438-46.
103. Rodriguez JR, Madanat MG, Healy BC, Thayer SP, Warshaw AL, Fernández CC. Distal pancreatectomy with splenic preservation revisited. Surgery 2007; 141:619-25. (Pubitemid 46616933)
104. Kobayashi G, Fujita N, Noda Y, Kimura K, Yago A, Yamazaki T, et al. Histological features and prognosis of mucinous cystic tumors of the pancreas. In: Wakui A, Yamauchi H, Ouchi K, editors. Carcinoma of the pancreas and biliary tract. Tohoku University Press; 1999. p. 213-8.
105. Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001;88:376-81. (Pubitemid 32238699)
106. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 1998;228: 685-91.
107. Blanc B, Sauvanet A, Couvelard A, Pessaux P, Dokmak S, Vullierme MP, et al. Limited pancreatic resections for intraductal papillary mucinous neoplasm. J Chir (Paris) 2008;145:568-78 [in French with English abstract].
108. Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg 2008;95:85-91. (Pubitemid 351184919)
109. Crippa S, Partelli S, Falconi M. Extent of surgical resections for intraductal papillary mucinous neoplasms. World J Gastrointest Surg 2010;2:347-51.
110. Takeyoshi I, Ohwada S, Nakamura S, Ogawa T, Kawashima Y, Ikeya T, et al. Segmental pancreatectomy for mucin-producing pancreatic tumors. Hepatogastroenterology 1999;46:2585-8. (Pubitemid 29454148)
111. Warshaw AL, Rattner DW, Fernández CC, Z'Graggen K. Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue. Arch Surg 1998;133:327-31. (Pubitemid 28154998)
112. Sperti C, Pasquali C, Ferronato A, Pedrazzoli S. Median pancreatectomy for tumors of the neck and body of the pancreas. J Am Coll Surg 2000;190:711-6.
113. Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. Role of medial pancreatectomy in the management of intraductal papillary mucinous neoplasms and islet cell tumors of the pancreatic neck and body. Dig Surg 2008;25:46-51. (Pubitemid 351560595)
114. Sauvanet A, Partensky C, Sastre B, Gigot JF, Fagniez PL, Tuech JJ, et al. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery 2002;132:836-43. (Pubitemid 36307822)
115. Adham M, Giunippero A, Hervieu V, Courbiere M, Partensky C. Central pancreatectomy: single-center experience of 50 cases. Arch Surg 2008;143: 175-80. discussion 80-81. (Pubitemid 351281630)
116. Kimura W, Fuse A, Hirai I, Suto K. Spleen-preserving distal pancreatectomy for intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology 2004;51:86-90. (Pubitemid 38283065)
117. Talamini MA, Moesinger R, Yeo CJ, Poulose B, Hruban RH, Cameron JL, et al. Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg 1998;227:896-903. (Pubitemid 29119537)
118. Madura JA, Yum MN, Lehman GA, Sherman S, Schmidt CM. Mucin secreting cystic lesions of the pancreas: treatment by enucleation. Am Surg 2004;70: 106-12.
119. Sciaudone G, Perniceni T, Levy P, Bougaran J, Gayet B. Enucleation of intraductal papillary-mucinous tumor of the head of the pancreas. Report of 2 cases. Gastroenterol Clin Biol 2000;24:121-4 [in French with English abstract]. (Pubitemid 30117245)
120. Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, et al. Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 2004; 8:713-9. (Pubitemid 39200819)
121. Cho A, Arita S, Koike N, Isaka N, Kusume K, Makino H, et al. Ventral pancreatectomy associated with segmental duodenectomy including the major papilla. Hepatogastroenterology 2007;54:2392-4.
122. Ohwada S, Ogawa T, Kasahara M, Kawate S, Koyama T, Izumi M, et al. Ventral pancreas-preserving pancreatic head and body resection. Hepatogastroenterology 2001;48:1622-4. (Pubitemid 34003489)
123. Sharma MS, Brams DM, Birkett DH, Munson JL. Uncinatectomy: a novel surgical option for the management of intraductal papillary mucinous tumors of the pancreas. Dig Surg 2006;23:121-4. (Pubitemid 44174852)
124. Yamaguchi K, Shimizu S, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M. Ductal branch-oriented minimal pancreatectomy: two cases of successful treatment. J Hepatobiliary Pancreat Surg 1999;6:69-73.
125. Lee SE, Jang JY, Yang SH, Kim SW. Intraductal papillary mucinous carcinoma with atypical manifestations: report of two cases. World J Gastroenterol 2007;13:1622-5. (Pubitemid 46679460)
126. Mizuta Y, Akazawa Y, Shiozawa K, Ohara H, Ohba K, Ohnita K, et al. Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 2005;5:470-4. (Pubitemid 41160290)
127. Vijan SS, Ahmed KA, Harmsen WS, Que FG, Reid-Lombardo KM, Nagorney DM, et al. Laparoscopic vs open distal pancreatectomy: a singleinstitution comparative study. Arch Surg 2010;145:616-21.
128. Gumbs AA, Gres P, Madureira FA, Gayet B. Laparoscopic vs. open resection of noninvasive intraductal pancreatic mucinous neoplasms. J Gastrointest Surg 2008;12:707-12.
129. Pryor A, Means JR, Pappas TN. Laparoscopic distal pancreatectomy with splenic preservation. Surg Endosc 2007;21:2326-30. (Pubitemid 350125961)
130. Hawes RH. The evolution of endoscopic ultrasound: improved imaging, higher accuracy for fine needle aspiration and the reality of endoscopic ultrasound-guided interventions. Curr Opin Gastroenterol 2010;26: 436-44.
131. Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc 2005;61: 746-52. (Pubitemid 40603050)
132. Oh HC, Seo DW, Lee TY, Kim JY, Lee SS, Lee SK, et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008;67:636-42.
133. Oh HC, Seo DW, Song TJ, Moon SH, Park DH, Soo Lee S, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology 2011;140:172-9.
134. DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc 2009;70:710-23.
135. Oh HC, Seo DW, Yu E, Kim SC, Moon SH, Park do H, et al. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol 2009;44:242-7.
136. Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57:1561-5.
137. Yamaguchi K, Nakamura K, Yokohata K, Shimizu S, Chijiiwa K, Tanaka M. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol 1997;22:227-31. (Pubitemid 28070888)
138. Sawai Y, Yamao K, Bhatia V, Chiba T, Mizuno N, Sawaki A, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 2010;42:1077-84.
139. Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 2009;15:7737-43.
140. Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 2010;251:470-6.
141. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004;239:400-8. (Pubitemid 38229071)
142. Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-48. (Pubitemid 38856838)
143. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15: 1087-95.
144. Nakagohri T, Asano T, Kenmochi T, Urashima T, Ochiai T. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 2002;26:1166-9. (Pubitemid 36920277)
145. Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2008;32:243-55. (Pubitemid 351172139)
146. Takahashi H, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, et al. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol 2006;13: 955-60.
147. Nakata K, Ohuchida K, Aishima S, Sadakari Y, Kayashima T, Miyasaka Y, et al. Invasive carcinomaderived fromintestinal-type intraductal papillarymucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas 2011;40:581-7.
148. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
149. Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 2011;60:509-16.
150. Luttges J, Zamboni G, Longnecker D, Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-8. (Pubitemid 32594989)
151. Furukawa T, Klöppel G, Adsay NV, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447:794-9. (Pubitemid 41728866)
152. Sadakari Y, Ohuchida K, Nakata K, Ohtsuka T, Aishima S, Takahata S, et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010;147:812-7.
153. Mino-Kenudson M, Fernández-del Castillo C, Baba Y, Valsangkar NP, Liss AS, Hsu M, et al. Prognosis of invasive IPMN depends on histological and precursor epithelial subtypes. Gut 2011;60:1712-20.
154. Basturk O, Khayyata S, Klimstra DS, Hruban RH, Zamboni G, Coban I, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol 2010;34:364-70.
155. Adsay NV, Adair CF, Heffess CS, Klimstra DS. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996;20:980-94. (Pubitemid 26250638)
156. Patel SA, Adams R, Goldstein M, Moskaluk CA. Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol 2002;26:1071-7. (Pubitemid 34810570)
157. Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, et al. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2007;34:197-204. (Pubitemid 46294795)
158. Gigot JF, Deprez P, Sempoux C, Descamps C, Metairie S, Glineur D, et al. Surgical management of intraductal papillary mucinous tumors of the pancreas: the role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis. Arch Surg 2001;136:1256-62. (Pubitemid 33043512)
159. Paye F, Sauvanet A, Terris B, Ponsot P, Vilgrain V, Hammel P, et al. Intraductal papillary mucinous tumors of th pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000;127:536-44. (Pubitemid 30257512)
160. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-87. (Pubitemid 38971421)
161. Basturk O, Coban I, Adsay NV. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 2009; 133:423-38.
162. Pour PM, Konishi Y, Kloppel G, Longnecker DS, editors. Atlas of exocrine pancreatic tumors, morphology, biology, and diagnosis with an international guide for tumor classification. Tokyo: Springer-Verlag; 1994. p. pp265-279.
163. Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484-90. (Pubitemid 36151345)
164. Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011;40:571-80.
165. Sawhney MS, Devarajan S, O'Farrel P, Cury MS, Kundu R, Vollmer CM, et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009;69:1106-10.
166. Shen J, Brugge WR, Dimaio CJ, Pitman MB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer Cytopathol 2009;117:217-27.
167. Toll AD, Kowalski T, Loren D, Bibbo M. The added value of molecular testing in small pancreatic cysts. JOP 2010;11:582-6.
168. Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010;251:70-5.
169. Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol 2006;4:1265-70. (Pubitemid 44512221)
170. Tanno S, Nakano Y, Koizumi K, Sugiyama Y, Nakamura K, Sasajima J, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas 2010;39: 36-40.
171. Ikeuchi N, Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, et al. Prognosis of cancer with branch duct type IPMN of the pancreas. World J Gastroenterol 2010;16:1890-5.
172. Tanno S, Nakano Y, Sugiyama Y, Nakamura K, Sasajima J, Koizumi K, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 2010;10:173-8.
173. Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, Sadakari Y, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg; 2011 [Epub ahead of print].
174. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152-61. (Pubitemid 30191880)
175. Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 2005;137:597-605. (Pubitemid 40755415)
176. Tien YW, Hu RH, Hung JS, Wang HP, Lee PH. Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy. Ann Surg Oncol 2008;15:193-8.
177. Azar C, Van de Stadt J, Rickaert F, Deviere M, Baize M, Kloppel G, et al. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39:457-64. (Pubitemid 26338538)
178. Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005;189:632-6. discussion 637.
179. Sugiura H, Kondo S, Islam HK, Ito K, Ono K, Morikawa T, et al. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology 2002;49:263-7. (Pubitemid 34289534)
180. Cellier C, Cuillerier E, Palazzo L, Rickaert F, Flejou JF, Napoleon B, et al. Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc 1998;47:42-9. (Pubitemid 28065305)
181. Niedergethmann M, Grutzmann R, Hildenbrand R, Dittert D, Aramin N, Franz M, et al. Outcome of invasive and noninvasive intraductal papillarymucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 2008;32:2253-60.
182. Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-22. (Pubitemid 35216862)
183. Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, et al. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 2008;36: 50-5.
184. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-8. (Pubitemid 38523922)
185. Amundadottier LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1:e65.
186. Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. Panc PRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 2007;25:1417-22. (Pubitemid 46706891)
187. Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M, et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007;16:342-6. (Pubitemid 46383356)
188. Goggins M, Schutte M, Lu J, Weinstein CL, Petersen GM, Yeo CJ, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-4. (Pubitemid 27011364)
189. Gruis NA, Sandkuiji LA, van der Velden PA, Bergman W, Frants RR. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiplemole melanoma (FAMMM) syndrome families. Melanoma Res 1995;5: 169-77.
190. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 1991;6:127-31.
191. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92:1260-6. (Pubitemid 30627734)
192. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-4. (Pubitemid 17076235)
193. Yamaguchi K, Chijiiwa K, Shimizu S, Yokohata K, Morisaki T, Yonemasu H, et al. Intraductal papillary neoplasm of the pancreas: a clinical review of 13 benign and four malignant tumours. Eur J Surg 1999;165:223-9. (Pubitemid 29374450)
194. Calculli L, Pezzilli R, Brindisi C, Morabito R, Casadei R, Zompatori M. Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience. Radiol Med 2010;115:442-52.
195. Oh SJ, Lee SJ, Lee HY, Paik YH, Lee DK, Lee KS, et al. Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas. Korean J Gastroenterol 2009;54:162-6 [in Korean with English abstract].
196. Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999;94:470-3. (Pubitemid 29084671)
197. Benarroch-Gampel J, Riall TS. Extrapancreatic malignancies and intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2010;2:363-7.
198. Reid-Lombardo KM, Mathis KL, Wood CM, Harmsen WS, Sarr MG. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg 2010; 251:64-9.
199. Lee SY, Choi DW, Jang KT, Lee KT, Choi SH, Heo JS, et al. High expression of intestinal-type mucin (MUC2) in intraductal papillary mucinous neoplasms coexisting with extrapancreatic gastrointestinal cancers. Pancreas 2006;32: 186-9.
200. Khan S, Sclabas G, Reid-Lombardo KM. Population-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patients. World J Gastrointest Surg 2010;2:314-8.